Vir Biotechnology (VIR) Intangibles (2018 - 2026)
Vir Biotechnology recorded quarterly Intangibles of $7.8 million in Q1 2026, down 0.93% quarter-over-quarter from $7.8 million in Q4 2025, and down 3.65% year-over-year from $8.1 million in Q1 2025.
Vir Biotechnology's Intangibles history runs 9 years deep, the most recent figure standing at $7.8 million for Q1 2026.
- In Q1 2026, Intangibles fell 3.65% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $7.8 million (down 3.65% YoY), while the FY2025 annual figure was $7.8 million, down 3.33% from the prior year.
- Intangibles came in at $7.8 million for Q1 2026 at Vir Biotechnology, down from $7.8 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $33.2 million in Q1 2022 to a low of $7.8 million in Q1 2026.
- A 5-year average of $20.4 million and a median of $22.5 million in 2024 frame the typical range for Intangibles.
- Across the five-year window, Intangibles fell 1.58% in 2022 and plunged 64.07% in 2025, its largest moves.
- Vir Biotechnology's Intangibles stood at $32.8 million in 2022, then slumped by 31.11% to $22.6 million in 2023, then plunged by 64.02% to $8.1 million in 2024, then slipped by 3.33% to $7.8 million in 2025, then fell by 0.93% to $7.8 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $7.8 million, $7.8 million, and $7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | 7.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.78 Mn |
| Dec 31, 2025 | 7.85 Mn |
| Sep 30, 2025 | 7.92 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 8.07 Mn |
| Dec 31, 2024 | 8.12 Mn |
| Sep 30, 2024 | 19.26 Mn |
| Jun 30, 2024 | 18.90 Mn |
| Mar 31, 2024 | 22.47 Mn |
| Dec 31, 2023 | 22.57 Mn |
| Sep 30, 2023 | 25.46 Mn |
| Jun 30, 2023 | 25.59 Mn |
| Mar 31, 2023 | 32.62 Mn |
| Dec 31, 2022 | 32.76 Mn |
| Sep 30, 2022 | 32.89 Mn |
| Jun 30, 2022 | 33.02 Mn |
| Mar 31, 2022 | 33.15 Mn |
| Dec 31, 2021 | 33.29 Mn |
| Sep 30, 2021 | 33.42 Mn |
| Jun 30, 2021 | 33.55 Mn |
| Mar 31, 2021 | 33.69 Mn |
| Dec 31, 2020 | 33.82 Mn |
| Sep 30, 2020 | 33.94 Mn |
| Jun 30, 2020 | 35.08 Mn |
| Mar 31, 2020 | 35.39 Mn |
| Dec 31, 2019 | 35.69 Mn |
| Sep 30, 2019 | 36.00 Mn |
| Dec 31, 2018 | 36.92 Mn |